Urinary frequency, enuresis and incontinence
Drug Safety Update
October 2015: Mirabegron (Betmiga▼): risk of severe hypertension and associated cerebrovascular and cardiac events
NICE Guidance (also see drug-specific links below)
CG97: Lower urinary tract symptoms in men: management, June 2015
CG171: Urinary incontinence in women: management, updated November 2015
CG148: Urinary incontinence in neurological disease: assessment and management, August 2012
TA290: Mirabegron for treating symptoms of overactive bladder, June 2013
Not for use in the frail/elderly patient
| Pack | Price |
|---|---|
| 56 tablet (8 x 7 tablets) | £2.55 |
| 84 tablet (12 x 7 tablets) | £3.53 |
| Pack | Price |
|---|---|
| 56 tablet | £17.91 |
| Pack | Price |
|---|---|
| 56 tablet (8 x 7 tablets) | £3.09 |
| Pack | Price |
|---|---|
| 30 tablet | £13.77 |
| Pack | Price |
|---|---|
| 30 tablet | £27.54 |
| Pack | Price |
|---|---|
| 8 patch | £27.20 |
| Pack | Price |
|---|---|
| 150 ml | £214.84 |
| Pack | Price |
|---|---|
| 56 tablet (4 x 14 tablets) | £31.50 |
| Pack | Price |
|---|---|
| 56 tablet (4 x 14 tablets) | £31.50 |
| Pack | Price |
|---|---|
| 28 capsule (2 x 14 capsules) | £12.89 |
| Pack | Price |
|---|---|
| 28 tablet (2 x 14 tablets) | £25.48 |
| Pack | Price |
|---|---|
| 28 tablet (2 x 14 tablets) | £25.48 |
| Pack | Price |
|---|---|
| 28 tablet (4 x 7 tablets) | £25.78 |
| Pack | Price |
|---|---|
| 28 tablet (4 x 7 tablets) | £25.78 |
Higher dose is much more expensive than other antimuscarinics - use for existing patients only
| Pack | Price |
|---|---|
| 30 tablet (3 x 10 tablets) | £27.62 |
| Pack | Price |
|---|---|
| 30 tablet (3 x 10 tablets) | £35.91 |
Mirabegron is the first in a new class of drugs it is a beta-3-adrenoceptor agonist. It is reserved for those patients for whom antimuscarinics are contraindicated or clinically ineffective, or have unacceptable side effects.
| Pack | Price |
|---|---|
| 30 tablet (3 x 10 tablets) | £29.00 |
| Pack | Price |
|---|---|
| 30 tablet (3 x 10 tablets) | £29.00 |